Skip to main content
. 2021 Aug 24;21:397. doi: 10.1186/s12888-021-03260-9

Table 3.

Study Characteristics and Findings—Secondary Analyses Testing PS as a Predictor, Moderator, or Mediator of Treatment Response

Study Country N Participant age range (mean) in years Diagnostic Status Recruitment Setting Overarching intervention(s) Effect type Operationalization of problem solving Outcome Effect
Becker-Weidman et al. [70] USA 439 a 12–17 (14.6) MDD Clinical

1. Fluox

2. CBT

3. Fluox + CBT

4. Placebo

Pred / Mod Baseline PPO, NPO, AS, ICS, RPS,

Depression severity

(CDRS-R)

NPO, PPO, AS = Pred**
Kennard et al. [71] USA 166 b 12–18 (16.0) MDD (TR) Clinical

Switch to:

1. Diff SSRI

2. Diff. SSRI + CBT

3. Ven

4. Ven + CBT

Pred Receipt of PS training as part of CBT vs. no receipt Treatment response (CDRS-R & CGI-I) PS training receipt = Pred*
Kaufman et al. [72] USA 93 a 13–17 (15.1) MDD & CD Community

1. CWD-A

2. LST

Med Δ self-reported PS in specific situations

Depression severity

(BDI-II & HDRS)

No significant effect
Dietz et al. [73] USA 63 a 13–18 (15.6) MDD Clinical

1. CBT

2. SBFT

3. NST

Med Δ observed interpersonal PS interactions between youth and mothers

MDD remission

(K-SADS & BDI).

Δ in PS interactions associated with outcome in CBT** and SFBT* but test for formal mediation not significant

Note. Δ: Change in; AS: Avoidance Style; BDI: Beck Depression Inventory [74]; CD: Conduct disorder; CDRS-R: Children’s Depression Rating Scale—Revised [75]; CGI-I: Clinical Global Impression Scale—Improvement [76]; CWD-A: Adolescent Coping with Depression Course; Diff: different; Fluox: Fluoxetine; ICS: Impulsivity/Carelessness Style; K-SADS: The Kiddie Schedule for Affective Disorders and Schizophrenia [77]; LST: Lifeskills training; MDD: Major Depressive Disorder; Med: Mediator; Mod: Moderator; NPO: Negative Problem Orientation; NST: Nondirective supportive therapy; PPO: Positive Problem Orientation; Pred: Predictor; RPS: Rational Problem Solving Style; SBFT: Systemic Behaviour Family Therapy; SPSI-R: Social Problem-Solving Inventory Revised [78]; SSRI: Selective serotonin reuptake inhibitors; TR: Treatment-resistant; Ven: Venlafaxine

* p < .05; ** p < .01; *** p < .001

a The total sample size reported is the number of participants randomized to intervention and control conditions

b The total sample size reported here is the number of participants randomized to an SSRI + CBT intervention arm